McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

ORIEN to Present Abstracts at 65th Annual ASH Meeting Utilizing Aster Insights’ Avatar Platform

by McKesson Ventures | Dec 8, 2023 | Press Releases

Aster Insights has announced three upcoming presentations at the 2023 American Society of Hematology (ASH) Annual Meeting, which will be held from December 9-12 in San Diego, CA. Three ORIEN scientists from Moffitt Cancer Center will present key findings on multiple...

New Study Shows Point-of-care Genetics May Improve Uptake, Reduce Racial Disparities

by McKesson Ventures | Dec 7, 2023 | Press Releases

On Thursday, December 7, 2023, oncology and cancer-health screening company Cancer IQ announced a partnership with the Boston University School of Public Health to study racial and ethnic disparities in genetic counseling and testing for at-risk cancer patients. This...

Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss

by McKesson Ventures | Dec 4, 2023 | Press Releases

Telemedicine company Hims & Hers announced the launch of its new weight loss service, “Weight Loss by Hims & Hers,” in a press release on Monday, December 4, 2023. The new service aims to establish itself as a holistic alternative to traditional weight loss...

Aledade and Anthem Announce New Medicaid Partnership to Bring the Benefits of Value-Based Care to More Virginians

by McKesson Ventures | Nov 30, 2023 | Press Releases

On Thursday, November 30, 2023, Aledade Inc. announced that it has partnered with Anthem Blue Cross and Blue Shield to increase quality and ease of access for patient care to people throughout the Commonwealth of Virginia. The initiative will provide improved and more...

Densitas® Selects CancerIQ to Power Lifetime Risk, Patient Adherence as Part of its Industry Leading Mammography Quality AI Platform

by McKesson Ventures | Nov 26, 2023 | Press Releases

Densitas Inc, an artificial intelligence and technology company, announced on Sunday that it has partnered with the cancer prevention service CancerIQ to include Cancer IQ’s Tyrer-Cuzick Version 8 risk calculator in its breast cancer screening offerings. This 8th...

Aster Insights Announces Presentations at SITC’s 38th Annual Meeting

by McKesson Ventures | Oct 31, 2023 | Press Releases

Aster Insights has announced that it will participate in the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting this November, with three presentations on the agenda. This year’s SITC Annual Meeting will be held in San Diego, CA, from November 1-5....
Page 5 of 41« First«...34567...102030...»Last »

Recent Posts

  • Saama Unveils Industry-first AI-Powered Tables, Listings, and Figures (TLF) Analyzer to Transform Clinical Study Reporting
  • McKesson Ventures Announces Expansion Into Growth Equity and Welcomes Peter Lafer as Head of Growth Investing
  • Oath Surgical Raises $24M to Build the First Surgeon-Owned, AI-Powered Surgical System
  • Lumata Health Improves Patient Adherence to Vision-Saving Treatments by Alleviating Barriers to Care
  • Saama Introduces Modular and Adaptive AI Agents For Clinical Innovation
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

 

Contact Us

In the News

Reimagine Care and Memorial Hermann Health System Unveil Expanded On-Demand Cancer Care Partnership

HarmonyCares Secures $200M to Expand Access to In-Home Primary Care

ChatRWD™ Beta from Atropos Health Exceeds Big Tech LLMs on Physician Trust and Ability to Answer Questions Completely with High-Quality Evidence in New Study

Atropos Health Raises $33M To Scale The Automation Of High-Quality, Personalized Real-World Evidence Leveraging Generative AI

©2025 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
  • Follow